Cargando…

Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film

BACKGROUND: Long-term use of topical, especially benzalkonium chloride (BAC)-preserved, antiglaucoma medications can cause a negative impact on the ocular surface. The aim of the study was to assess the effect of topical carbonic anhydrase inhibitors (CAIs) on selected oxidative stress biomarkers in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlak, Lech, Świerczyńska, Marta, Borymska, Weronika, Zych, Maria, Wyględowska-Promieńska, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411550/ https://www.ncbi.nlm.nih.gov/pubmed/34470600 http://dx.doi.org/10.1186/s12886-021-02079-y

Ejemplares similares

Allergic contact dermatitis to dorzolamide and benzalkonium chloride
por: Orsini, Diego, et al.
Publicado: (2018)

Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
por: Sedlak, Lech, et al.
Publicado: (2019)

Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy–Case Report
por: Sedlak, Lech, et al.
Publicado: (2023)

Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
por: Tokuda, Naoto, et al.
Publicado: (2017)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
por: Nakamura, Yoshimi, et al.
Publicado: (2009)

Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report
por: Świerczyńska, Marta, et al.
Publicado: (2023)

Choroidal neovascularization secondary to ocular syphilis
por: Świerczyńska, Marta Paula, et al.
Publicado: (2021)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
por: Galose, Mary S, et al.
Publicado: (2016)

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo, Julian, et al.
Publicado: (2016)

Effect of Resveratrol, a Dietary-Derived Polyphenol, on the Oxidative Stress and Polyol Pathway in the Lens of Rats with Streptozotocin-Induced Diabetes
por: Sedlak, Lech, et al.
Publicado: (2018)

Effect of caffeine on biomarkers of oxidative stress in lenses of rats with streptozotocin-induced diabetes
por: Kaczmarczyk-Sedlak, Ilona, et al.
Publicado: (2019)

Comparison of Cytotoxic Effects on Rabbit Corneal Endothelium between Preservative-free and Preservative-containing Dorzolamide/timolol
por: Kwon, Junki, et al.
Publicado: (2015)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
por: Lo, Jonathan S, et al.
Publicado: (2016)

Tolerability and effectiveness of preservative-free dorzolamide–timolol (preservative-free COSOPT(®)) in patients with open-angle glaucoma or ocular hypertension
por: Hutnik, Cindy, et al.
Publicado: (2010)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension
por: Sanseau, Ana, et al.
Publicado: (2013)

Patient perspectives when switching from Cosopt(®) (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
por: Auger, Graham Anthony, et al.
Publicado: (2012)

Stereoselective Solvolysis in the Synthesis of Dorzolamide Intermediates
por: Martinelli, Andrea, et al.
Publicado: (2023)

Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite
por: Unković, Nikola, et al.
Publicado: (2015)

Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops
por: Seo, Du Ri, et al.
Publicado: (2015)

Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Inoue, Kenji, et al.
Publicado: (2011)

Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015)

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
por: Altafini, Romeo, et al.
Publicado: (2015)

Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
por: Ayaki, Masahiko, et al.
Publicado: (2010)

Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells
por: Hedengran, Anne, et al.
Publicado: (2024)

Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system
por: Ryan, Gerard, et al.
Publicado: (2011)

Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
por: LOPES, Nara Lidia Vieira, et al.
Publicado: (2019)

Effect of dorzolamide/timolol combination on the visual field in glaucoma
por: Takeda, Sakurako, et al.
Publicado: (2014)

Dramatic response to topical dorzolamide in X-linked retinoschisis
por: Thangavel, Rajeswari, et al.
Publicado: (2020)

Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells
por: Ammar, David A., et al.
Publicado: (2011)

Research on the Stability of a Rabbit Dry Eye Model Induced by Topical Application of the Preservative Benzalkonium Chloride
por: Li, Chaoyang, et al.
Publicado: (2012)

The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats
por: Slenter, Inge J. M., et al.
Publicado: (2019)

Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient
por: Kiszkielis, Marta, et al.
Publicado: (2013)

Correction: Research on the Stability of a Rabbit Dry Eye Model Induced by Topical Application of the Preservative Benzalkonium Chloride
por: Li, Chaoyang, et al.
Publicado: (2012)

Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications
por: Liu, Xing, et al.
Publicado: (2015)

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
por: Rosin, Lauren M, et al.
Publicado: (2013)

The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
por: Datta, Sandipan, et al.
Publicado: (2017)

A patient preference comparison of Azarga(™) (brinzolamide/timolol fixed combination) vs Cosopt(®) (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension
por: Mundorf, Thomas K, et al.
Publicado: (2008)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

Anaphylaxis Caused by Benzalkonium in a Nebulizer Solution
por: Kim, Sang-Hoon, et al.
Publicado: (2004)

Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v4u4u6k8rijml9j0s89pql4lt8